DIFFUSE-TYPE GIANT CELL TUMOR

Clinical trials for DIFFUSE-TYPE GIANT CELL TUMOR explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE-TYPE GIANT CELL TUMOR trials appear

Sign up with your email to follow new studies for DIFFUSE-TYPE GIANT CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Cancer drug repurposed to fight rare, recurring joint tumor

Disease control Completed

This study tested whether nilotinib, a drug used for leukemia, could help control a rare, non-cancerous joint tumor called pigmented villonodular synovitis (PVNS) when it comes back or spreads. Seventeen adults with recurrent or metastatic PVNS took nilotinib pills twice daily. T…

Matched conditions: DIFFUSE-TYPE GIANT CELL TUMOR

Phase: PHASE2 • Sponsor: Andrew J. Wagner, MD, PhD • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

DIFFUSE-TYPE GIANT CELL TUMOR

Get alerted when new DIFFUSE-TYPE GIANT CELL TUMOR trials appear

Cancer drug repurposed to fight rare, recurring joint tumor